0	0	1999-09-22	CD	O	O	B-Num
0	1	21	CD	O	O	B-Num
0	2	:	:	O	O	I-Num
0	3	44	CD	O	B-NP	I-Num
0	4	NUMBER	NN	O	I-NP	O
0	5	OF	IN	O	B-PP	O
0	6	HUMAN	NNP	O	B-NP	B-Animal
0	7	GENES	NNP	O	I-NP	O
0	8	IS	VBZ	O	B-VP	O
0	9	PUT	NNP	O	B-NP	O
0	10	AT	IN	O	B-PP	O
0	11	140COMMA000	CD	O	B-NP	B-Num
0	12	COMMA	COMMA	O	O	O
0	13	A	DT	O	O	O
0	14	SIGNIFICANT	NNP	O	O	B-Org
0	15	GAIN	NNP	O	O	I-Org

1	0	A	DT	O	B-NP	O
1	1	new	JJ	O	I-NP	O
1	2	calculation	NN	O	I-NP	O
1	3	of	IN	O	B-PP	O
1	4	the	DT	O	B-NP	O
1	5	number	NN	O	I-NP	O
1	6	of	IN	O	B-PP	O
1	7	human	JJ	O	B-NP	B-Animal
1	8	genes	NNS	O	I-NP	O
1	9	puts	VBZ	O	B-VP	O
1	10	the	DT	O	B-NP	O
1	11	total	NN	O	I-NP	O
1	12	far	RB	O	O	O
1	13	higher	JJR	O	O	O
1	14	than	IN	O	B-PP	O
1	15	previous	JJ	O	B-NP	O
1	16	estimates	NNS	O	I-NP	O
1	17	COMMA	COMMA	O	O	O
1	18	meaning	VBG	O	B-VP	O
1	19	that	IN	O	O	O
1	20	the	DT	O	B-NP	O
1	21	human	JJ	O	I-NP	B-Animal
1	22	organism	NN	O	I-NP	O
1	23	is	VBZ	O	B-VP	O
1	24	considerably	RB	O	B-NP	O
1	25	more	RBR	O	I-NP	O
1	26	complex	NN	O	I-NP	O
1	27	than	IN	O	B-PP	O
1	28	hitherto	RB	O	O	O
1	29	expected	VBN	O	B-VP	O
1	30	.	.	O	O	O

2	0	The	DT	O	B-NP	O
2	1	new	JJ	O	I-NP	O
2	2	estimate	NN	O	I-NP	O
2	3	COMMA	COMMA	O	O	O
2	4	by	IN	O	B-PP	O
2	5	Incyte	NNP	O	B-NP	B-Peop
2	6	Pharmaceuticals	NNP	O	I-NP	I-Peop
2	7	of	IN	O	B-PP	O
2	8	Palo	NNP	O	B-NP	B-LocCit
2	9	Alto	NNP	O	I-NP	I-LocCit
2	10	COMMA	COMMA	O	O	O
2	11	Calif.	NNP	O	B-NP	B-LocStat
2	12	COMMA	COMMA	O	O	O
2	13	sets	VBZ	O	B-VP	O
2	14	the	DT	O	B-NP	O
2	15	number	NN	O	I-NP	O
2	16	of	IN	O	B-PP	O
2	17	human	JJ	O	B-NP	B-Animal
2	18	genes	NNS	O	I-NP	O
2	19	at	IN	O	B-PP	O
2	20	140COMMA000	CD	O	B-NP	B-Num
2	21	.	.	O	O	O

3	0	Each	DT	O	B-NP	O
3	1	gene	NN	O	I-NP	O
3	2	specifies	VBZ	O	B-VP	O
3	3	the	DT	O	B-NP	O
3	4	manufacture	NN	O	I-NP	O
3	5	of	IN	O	B-PP	O
3	6	one	CD	O	B-NP	B-Num
3	7	or	CC	O	I-NP	O
3	8	more	JJR	O	I-NP	O
3	9	proteins	NNS	O	I-NP	O
3	10	COMMA	COMMA	O	O	O
3	11	the	DT	O	B-NP	O
3	12	working	VBG	O	I-NP	O
3	13	parts	NNS	O	I-NP	O
3	14	of	IN	O	B-PP	O
3	15	the	DT	O	B-NP	O
3	16	body	NN	O	I-NP	O
3	17	.	.	O	O	O

4	0	As	IN	O	O	O
4	1	the	DT	O	B-NP	O
4	2	programming	NN	O	I-NP	O
4	3	instructions	NNS	O	I-NP	O
4	4	of	IN	O	B-PP	O
4	5	the	DT	O	B-NP	O
4	6	human	JJ	O	I-NP	B-Animal
4	7	cell	NN	O	I-NP	O
4	8	COMMA	COMMA	O	O	O
4	9	the	DT	O	B-NP	O
4	10	genes	NNS	O	I-NP	O
4	11	provide	VBP	O	B-VP	O
4	12	all	PDT	O	B-NP	O
4	13	the	DT	O	I-NP	O
4	14	information	NN	O	I-NP	O
4	15	needed	VBD	O	B-VP	O
4	16	to	TO	O	B-VP	O
4	17	develop	VB	O	I-VP	O
4	18	COMMA	COMMA	O	O	O
4	19	operate	VB	O	B-VP	O
4	20	and	CC	O	I-VP	O
4	21	maintain	VB	O	I-VP	O
4	22	the	DT	O	B-NP	O
4	23	human	JJ	O	I-NP	B-Animal
4	24	organism	NN	O	I-NP	O
4	25	.	.	O	O	O

5	0	The	DT	O	B-NP	O
5	1	new	JJ	O	I-NP	O
5	2	figure	NN	O	I-NP	O
5	3	was	VBD	O	B-VP	O
5	4	announced	VBN	O	I-VP	O
5	5	on	IN	O	B-PP	O
5	6	Monday	NNP	O	B-NP	B-Date
5	7	night	NN	O	I-NP	O
5	8	by	IN	O	B-PP	O
5	9	Dr.	NNP	O	B-NP	B-ProfTitle
5	10	Randy	NNP	O	I-NP	B-Peop
5	11	Scott	NNP	O	I-NP	I-Peop
5	12	COMMA	COMMA	O	O	O
5	13	president	NN	O	B-NP	B-ProfTitle
5	14	and	CC	O	O	O
5	15	chief	NN	O	B-NP	B-ProfTitle
5	16	scientific	JJ	O	I-NP	O
5	17	officer	NN	O	I-NP	B-ProfTitle
5	18	of	IN	O	B-PP	O
5	19	Incyte	NNP	O	B-NP	O
5	20	COMMA	COMMA	O	O	O
5	21	at	IN	O	B-PP	O
5	22	a	DT	O	B-NP	O
5	23	conference	NN	O	I-NP	O
5	24	in	IN	O	B-PP	O
5	25	Miami	NNP	O	B-NP	B-LocCit
5	26	held	VBD	O	B-VP	O
5	27	by	IN	O	B-PP	O
5	28	the	DT	O	B-NP	O
5	29	Institute	NNP	O	I-NP	O
5	30	for	IN	O	B-PP	O
5	31	Genomic	NNP	O	B-NP	O
5	32	Research	NNP	O	I-NP	B-OrgCorp
5	33	.	.	O	O	O

6	0	The	DT	O	B-NP	O
6	1	number	NN	O	I-NP	O
6	2	is	VBZ	O	B-VP	O
6	3	a	DT	O	B-NP	O
6	4	sharp	JJ	O	I-NP	O
6	5	upward	JJ	O	I-NP	O
6	6	revision	NN	O	I-NP	O
6	7	and	CC	O	O	O
6	8	one	CD	O	B-NP	B-Num
6	9	that	IN	O	O	O
6	10	points	NNS	O	B-NP	O
6	11	up	IN	O	B-PP	O
6	12	how	WRB	O	O	O
6	13	much	RB	O	O	O
6	14	there	EX	O	B-NP	O
6	15	is	VBZ	O	B-VP	O
6	16	still	RB	O	I-VP	O
6	17	to	TO	O	I-VP	O
6	18	learn	VB	O	I-VP	O
6	19	about	IN	O	B-PP	O
6	20	human	JJ	O	B-NP	B-Animal
6	21	genetic	JJ	O	I-NP	B-Medical
6	22	programming	NN	O	I-NP	O
6	23	.	.	O	O	O

7	0	The	DT	O	B-NP	O
7	1	C.	NNP	O	I-NP	B-Org
7	2	elegans	NNS	O	I-NP	O
7	3	roundworm	NN	O	I-NP	B-Animal
7	4	was	VBD	O	B-VP	O
7	5	thought	VBN	O	I-VP	O
7	6	to	TO	O	I-VP	O
7	7	have	VB	O	I-VP	O
7	8	about	IN	O	B-NP	O
7	9	12COMMA000	CD	O	I-NP	B-Num
7	10	genes	NNS	O	I-NP	O
7	11	until	IN	O	O	O
7	12	shortly	RB	O	O	O
7	13	before	IN	O	B-PP	O
7	14	its	PP$	O	O	O
7	15	genome	NN	O	O	B-Jour
7	16	was	VBD	O	B-VP	O
7	17	sequenced	VBN	O	I-VP	O
7	18	last	JJ	O	B-NP	O
7	19	year	NN	O	I-NP	O
7	20	COMMA	COMMA	O	O	O
7	21	when	WRB	O	O	O
7	22	it	PRP	O	B-NP	O
7	23	turned	VBD	O	B-VP	O
7	24	out	IN	O	O	O
7	25	to	TO	O	B-VP	O
7	26	have	VB	O	I-VP	O
7	27	19COMMA099	CD	O	B-NP	B-Num
7	28	genes	NNS	O	I-NP	O
7	29	.	.	O	O	O

8	0	So	IN	O	O	O
8	1	humans	NNS	O	B-NP	O
8	2	are	VBP	O	B-VP	O
8	3	receiving	VBG	O	I-VP	O
8	4	the	DT	O	B-NP	O
8	5	same	JJ	O	I-NP	O
8	6	kind	NN	O	I-NP	O
8	7	of	IN	O	B-PP	O
8	8	upgrade	NN	O	B-NP	O
8	9	in	IN	O	B-PP	O
8	10	complexity	NN	O	B-NP	O
8	11	as	IN	O	O	O
8	12	the	DT	O	B-NP	O
8	13	worm	NN	O	I-NP	B-Animal
8	14	.	.	O	O	O

9	0	Scott	NNP	O	B-NP	B-Peop
9	1	's	POS	O	B-NP	O
9	2	company	NN	O	I-NP	B-OrgCorp
9	3	provides	VBZ	O	B-VP	O
9	4	genetic	JJ	O	B-NP	B-Medical
9	5	information	NN	O	I-NP	O
9	6	to	TO	O	B-PP	O
9	7	pharmaceutical	JJ	O	B-NP	B-Medical
9	8	companies	NNS	O	I-NP	B-OrgCorp
9	9	COMMA	COMMA	O	O	O
9	10	as	IN	O	O	O
9	11	does	VBZ	O	B-VP	O
9	12	its	PP$	O	B-NP	O
9	13	rival	NN	O	I-NP	O
9	14	COMMA	COMMA	O	O	O
9	15	the	DT	O	B-NP	O
9	16	Celera	NNP	O	I-NP	B-OrgCorp
9	17	Corp.	NNP	O	I-NP	I-OrgCorp
9	18	of	IN	O	B-PP	O
9	19	Rockville	NNP	O	B-NP	B-Loc
9	20	COMMA	COMMA	O	O	O
9	21	Md.	NNP	O	B-NP	B-LocStat
9	22	COMMA	COMMA	O	O	O
9	23	headed	VBN	O	B-VP	O
9	24	by	IN	O	B-PP	O
9	25	Dr.	NNP	O	B-NP	B-ProfTitle
9	26	J.	NNP	O	I-NP	O
9	27	Craig	NNP	O	I-NP	B-Peop
9	28	Venter	NNP	O	I-NP	I-Peop
9	29	.	.	O	O	O

10	0	Scott	NNP	O	B-NP	B-Peop
10	1	's	POS	O	B-NP	O
10	2	estimate	NN	O	I-NP	O
10	3	for	IN	O	B-PP	O
10	4	the	DT	O	B-NP	O
10	5	total	JJ	O	I-NP	O
10	6	number	NN	O	I-NP	O
10	7	of	IN	O	B-PP	O
10	8	humans	NNS	O	B-NP	O
10	9	genes	NNS	O	I-NP	O
10	10	is	VBZ	O	B-VP	O
10	11	double	RB	O	O	O
10	12	that	IN	O	O	O
10	13	calculated	VBN	O	B-VP	O
10	14	by	IN	O	B-PP	O
10	15	Venter	NNP	O	B-NP	O
10	16	five	CD	O	B-NP	B-Num
10	17	years	NNS	O	I-NP	B-Date
10	18	ago	IN	O	O	O
10	19	.	.	O	O	O

11	0	At	IN	O	B-PP	O
11	1	that	DT	O	B-NP	O
11	2	time	NN	O	I-NP	O
11	3	COMMA	COMMA	O	O	O
11	4	Venter	NNP	O	B-NP	B-Peop
11	5	predicted	VBD	O	B-VP	O
11	6	60COMMA000	CD	O	B-NP	B-Num
11	7	to	TO	O	B-PP	O
11	8	80COMMA000	CD	O	B-NP	B-Num
11	9	human	JJ	O	I-NP	B-Animal
11	10	genes	NNS	O	I-NP	O
11	11	.	.	O	O	O

12	0	Many	JJ	O	B-NP	O
12	1	biologists	NNS	O	I-NP	O
12	2	use	VBP	O	B-VP	O
12	3	the	DT	O	B-NP	O
12	4	figure	NN	O	I-NP	O
12	5	of	IN	O	B-PP	O
12	6	100COMMA000	CD	O	B-NP	B-Num
12	7	human	JJ	O	I-NP	B-Animal
12	8	genes	NNS	O	I-NP	O
12	9	COMMA	COMMA	O	O	O
12	10	a	DT	O	O	O
12	11	round	VBP	O	B-VP	O
12	12	number	NN	O	B-NP	O
12	13	that	WDT	O	B-NP	O
12	14	implies	VBZ	O	B-VP	O
12	15	the	DT	O	B-NP	O
12	16	exact	JJ	O	I-NP	O
12	17	total	NN	O	I-NP	O
12	18	could	MD	O	B-VP	O
12	19	be	VB	O	I-VP	O
12	20	somewhat	RB	O	O	O
12	21	more	JJR	O	O	O
12	22	or	CC	O	O	O
12	23	less	JJR	O	O	O
12	24	.	.	O	O	O

13	0	The	DT	O	B-NP	O
13	1	Web	NNP	O	I-NP	B-Org
13	2	page	NN	O	I-NP	O
13	3	of	IN	O	B-PP	O
13	4	the	DT	O	B-NP	O
13	5	National	NNP	O	I-NP	B-Org
13	6	Human	NNP	O	I-NP	I-Org
13	7	Genome	NNP	O	I-NP	I-Org
13	8	Research	NNP	O	I-NP	I-Org
13	9	Institute	NNP	O	I-NP	I-Org
13	10	COMMA	COMMA	O	O	O
13	11	the	DT	O	B-NP	O
13	12	federal	JJ	O	I-NP	O
13	13	agency	NN	O	I-NP	B-OrgCorp
13	14	that	WDT	O	B-NP	O
13	15	provides	VBZ	O	B-VP	O
13	16	money	NN	O	B-NP	B-Money
13	17	for	IN	O	B-PP	O
13	18	the	DT	O	B-NP	O
13	19	major	JJ	O	I-NP	O
13	20	part	NN	O	I-NP	O
13	21	of	IN	O	B-PP	O
13	22	the	DT	O	B-NP	O
13	23	human	JJ	O	I-NP	B-Animal
13	24	genome	NN	O	I-NP	B-Jour
13	25	project	NN	O	I-NP	O
13	26	COMMA	COMMA	O	O	O
13	27	estimates	VBZ	O	B-VP	O
13	28	that	IN	O	O	O
13	29	there	EX	O	B-NP	O
13	30	are	VBP	O	B-VP	O
13	31	50COMMA000	CD	O	B-NP	B-Num
13	32	to	TO	O	I-NP	O
13	33	100COMMA000	CD	O	I-NP	B-Num
13	34	human	JJ	O	I-NP	B-Animal
13	35	genes	NNS	O	I-NP	O
13	36	.	.	O	O	O

14	0	Genes	NNP	O	B-NP	O
14	1	are	VBP	O	B-VP	O
14	2	small	JJ	O	O	O
14	3	COMMA	COMMA	O	O	O
14	4	selected	VBD	O	B-VP	O
14	5	sequences	NNS	O	B-NP	O
14	6	of	IN	O	B-PP	O
14	7	DNA	NNP	O	B-NP	B-Org
14	8	strung	NN	O	I-NP	O
14	9	out	IN	O	O	O
14	10	along	IN	O	B-PP	O
14	11	the	DT	O	B-NP	O
14	12	enormous	JJ	O	I-NP	O
14	13	DNA	NNP	O	I-NP	O
14	14	molecules	NNS	O	I-NP	B-Jour
14	15	that	DT	O	B-NP	O
14	16	form	VBP	O	B-VP	O
14	17	the	DT	O	B-NP	O
14	18	chromosomes	NNS	O	I-NP	O
14	19	.	.	O	O	O

15	0	One	CD	O	B-NP	B-Num
15	1	reason	NN	O	I-NP	O
15	2	for	IN	O	B-PP	O
15	3	the	DT	O	B-NP	O
15	4	wide	JJ	O	I-NP	O
15	5	uncertainty	NN	O	I-NP	O
15	6	over	IN	O	B-PP	O
15	7	the	DT	O	B-NP	O
15	8	number	NN	O	I-NP	O
15	9	of	IN	O	B-PP	O
15	10	human	JJ	O	B-NP	B-Animal
15	11	genes	NNS	O	I-NP	O
15	12	is	VBZ	O	B-VP	O
15	13	that	IN	O	O	O
15	14	there	EX	O	B-NP	O
15	15	is	VBZ	O	B-VP	O
15	16	no	DT	O	B-NP	O
15	17	sure	JJ	O	I-NP	O
15	18	way	NN	O	I-NP	O
15	19	of	IN	O	B-PP	O
15	20	telling	VBG	O	B-VP	O
15	21	where	WRB	O	O	O
15	22	on	IN	O	B-PP	O
15	23	a	DT	O	B-NP	O
15	24	sequence	NN	O	I-NP	O
15	25	of	IN	O	B-PP	O
15	26	DNA	NNP	O	B-NP	O
15	27	a	DT	O	B-NP	O
15	28	gene	NN	O	I-NP	O
15	29	starts	VBZ	O	B-VP	O
15	30	.	.	O	O	O

16	0	In	IN	O	B-PP	O
16	1	making	VBG	O	B-VP	O
16	2	its	PP$	O	B-NP	O
16	3	new	JJ	O	I-NP	O
16	4	estimate	NN	O	I-NP	O
16	5	COMMA	COMMA	O	O	O
16	6	Incyte	NNP	O	B-NP	B-Org
16	7	scientists	NNS	O	I-NP	B-ProfTitle
16	8	depended	VBD	O	B-VP	O
16	9	on	IN	O	B-PP	O
16	10	that	DT	O	B-NP	O
16	11	fact	NN	O	I-NP	O
16	12	that	IN	O	O	O
16	13	while	IN	O	O	O
16	14	biologists	NNS	O	B-NP	O
16	15	cannot	NN	O	I-NP	O
16	16	recognize	VB	O	B-VP	O
16	17	where	WRB	O	O	O
16	18	the	DT	O	B-NP	O
16	19	genes	NNS	O	I-NP	O
16	20	lie	VBP	O	B-VP	O
16	21	on	IN	O	B-PP	O
16	22	DNA	NNP	O	B-NP	O
16	23	COMMA	COMMA	O	O	O
16	24	human	JJ	O	B-NP	B-Animal
16	25	cells	NNS	O	I-NP	O
16	26	can	MD	O	B-VP	O
16	27	.	.	O	O	O

17	0	The	DT	O	B-NP	O
17	1	cell	NN	O	I-NP	O
17	2	's	POS	O	B-NP	O
17	3	machinery	NN	O	I-NP	O
17	4	transcribes	VBZ	O	B-VP	O
17	5	genes	NNS	O	B-NP	O
17	6	into	IN	O	B-PP	O
17	7	active	JJ	O	B-NP	O
17	8	copies	NNS	O	I-NP	O
17	9	known	VBN	O	B-VP	O
17	10	as	IN	O	B-PP	O
17	11	messenger	NN	O	B-NP	O
17	12	RNA	NNP	O	I-NP	B-ProfTitle
17	13	.	.	O	O	O

18	0	These	DT	O	B-NP	O
18	1	cellular	JJ	O	I-NP	O
18	2	messages	NNS	O	I-NP	O
18	3	can	MD	O	B-VP	O
18	4	be	VB	O	I-VP	O
18	5	captured	VBN	O	I-VP	O
18	6	and	CC	O	O	O
18	7	analyzed	VBD	O	B-VP	O
18	8	before	IN	O	O	O
18	9	they	PRP	O	B-NP	O
18	10	are	VBP	O	B-VP	O
18	11	naturally	RB	O	O	O
18	12	degraded	JJ	O	O	O
18	13	.	.	O	O	O

19	0	By	IN	O	B-PP	O
19	1	decoding	VBG	O	B-VP	O
19	2	the	DT	O	B-NP	O
19	3	heads	NNS	O	I-NP	O
19	4	and	CC	O	I-NP	O
19	5	tails	NNS	O	I-NP	O
19	6	of	IN	O	B-PP	O
19	7	as	IN	O	O	O
19	8	many	JJ	O	B-NP	O
19	9	messages	NNS	O	I-NP	O
19	10	as	IN	O	O	O
19	11	they	PRP	O	B-NP	O
19	12	could	MD	O	B-VP	O
19	13	find	VB	O	I-VP	O
19	14	COMMA	COMMA	O	O	O
19	15	Incyte	NNP	O	B-NP	O
19	16	biologists	NNS	O	I-NP	O
19	17	figured	VBD	O	B-VP	O
19	18	that	IN	O	O	O
19	19	the	DT	O	B-NP	O
19	20	total	JJ	O	I-NP	O
19	21	number	NN	O	I-NP	O
19	22	of	IN	O	B-PP	O
19	23	different	JJ	O	B-NP	O
19	24	genes	NNS	O	I-NP	O
19	25	in	IN	O	B-PP	O
19	26	the	DT	O	B-NP	O
19	27	full	JJ	O	I-NP	O
19	28	human	NN	O	I-NP	B-Animal
19	29	DNA	NN	O	I-NP	O
19	30	COMMA	COMMA	O	O	O
19	31	or	CC	O	O	O
19	32	genome	NN	O	B-NP	B-Jour
19	33	COMMA	COMMA	O	O	O
19	34	was	VBD	O	B-VP	O
19	35	130COMMA000	CD	O	B-NP	B-Num
19	36	.	.	O	O	O

20	0	Using	VBG	O	B-VP	O
20	1	an	DT	O	B-NP	O
20	2	independent	JJ	O	I-NP	O
20	3	method	NN	O	I-NP	O
20	4	COMMA	COMMA	O	O	O
20	5	based	VBN	O	B-PP	O
20	6	on	IN	O	B-PP	O
20	7	a	DT	O	B-NP	O
20	8	feature	NN	O	I-NP	O
20	9	known	VBN	O	B-VP	O
20	10	as	IN	O	B-PP	O
20	11	CG	NNP	O	B-NP	B-OrgCorp
20	12	islands	NNS	O	I-NP	O
20	13	that	IN	O	B-NP	O
20	14	occur	VBP	O	B-VP	O
20	15	in	IN	O	B-PP	O
20	16	about	IN	O	B-NP	O
20	17	half	NN	O	I-NP	O
20	18	of	IN	O	B-PP	O
20	19	known	VBN	O	B-NP	O
20	20	genes	NNS	O	I-NP	O
20	21	COMMA	COMMA	O	O	O
20	22	Incyte	NNP	O	B-NP	B-Peop
20	23	calculated	VBN	O	B-VP	O
20	24	143COMMA000	CD	O	B-NP	B-Num
20	25	genes	NNS	O	I-NP	O
20	26	in	IN	O	B-PP	O
20	27	every	DT	O	B-NP	O
20	28	cell	NN	O	I-NP	O
20	29	of	IN	O	B-PP	O
20	30	the	DT	O	B-NP	O
20	31	human	JJ	O	I-NP	B-Animal
20	32	body	NN	O	I-NP	O
20	33	.	.	O	O	O

21	0	Putting	VBG	O	B-VP	O
21	1	the	DT	O	B-NP	O
21	2	two	CD	O	I-NP	B-Num
21	3	estimates	NNS	O	I-NP	O
21	4	together	RB	O	O	O
21	5	produced	VBD	O	B-VP	O
21	6	the	DT	O	B-NP	O
21	7	figure	NN	O	I-NP	O
21	8	of	IN	O	B-PP	O
21	9	140COMMA000	CD	O	B-NP	B-Num
21	10	.	.	O	O	O

22	0	Venter	NNP	O	B-NP	B-Peop
22	1	said	VBD	O	B-VP	O
22	2	that	IN	O	O	O
22	3	no	DT	O	B-NP	O
22	4	region	NN	O	I-NP	O
22	5	of	IN	O	B-PP	O
22	6	the	DT	O	B-NP	O
22	7	human	JJ	O	I-NP	B-Animal
22	8	genome	NN	O	I-NP	B-Jour
22	9	that	WDT	O	B-NP	O
22	10	had	VBD	O	B-VP	O
22	11	been	VBN	O	I-VP	O
22	12	decoded	VBN	O	I-VP	O
22	13	so	RB	O	O	O
22	14	far	RB	O	O	O
22	15	contained	VBN	O	B-VP	O
22	16	as	IN	O	B-PP	O
22	17	many	JJ	O	B-NP	O
22	18	genes	NNS	O	I-NP	O
22	19	as	IN	O	B-PP	O
22	20	the	DT	O	B-NP	O
22	21	Incyte	NNP	O	I-NP	O
22	22	estimate	NN	O	I-NP	O
22	23	implied	VBD	O	B-VP	O
22	24	.	.	O	O	O

23	0	His	PP$	O	B-NP	O
23	1	earlier	JJR	O	I-NP	O
23	2	estimate	VB	O	I-NP	O
23	3	of	IN	O	B-PP	O
23	4	70COMMA000	CD	O	B-NP	B-Num
23	5	human	JJ	O	I-NP	B-Animal
23	6	genes	NNS	O	I-NP	O
23	7	COMMA	COMMA	O	O	O
23	8	he	PRP	O	B-NP	O
23	9	said	VBD	O	B-VP	O
23	10	COMMA	COMMA	O	O	O
23	11	assumes	VBZ	O	B-VP	O
23	12	that	IN	O	O	O
23	13	human	JJ	O	B-NP	B-Animal
23	14	cells	NNS	O	I-NP	O
23	15	have	VBP	O	B-VP	O
23	16	three	CD	O	B-NP	B-Num
23	17	billion	CD	O	I-NP	B-Num
23	18	units	NNS	O	I-NP	O
23	19	of	IN	O	B-PP	O
23	20	DNA	NNP	O	B-NP	O
23	21	.	.	O	O	O

24	0	If	IN	O	O	O
24	1	the	DT	O	B-NP	O
24	2	human	JJ	O	I-NP	B-Animal
24	3	genome	NN	O	I-NP	B-Jour
24	4	is	VBZ	O	B-VP	O
24	5	25	CD	O	B-NP	B-NumPercent
24	6	percent	NN	O	I-NP	I-NumPercent
24	7	larger	JJR	O	O	O
24	8	than	IN	O	B-PP	O
24	9	this	DT	O	B-NP	O
24	10	COMMA	COMMA	O	O	O
24	11	as	IN	O	B-PP	O
24	12	Celera	NNP	O	B-NP	B-Peop
24	13	's	POS	O	B-NP	O
24	14	recent	JJ	O	I-NP	O
24	15	work	NN	O	I-NP	O
24	16	on	IN	O	B-PP	O
24	17	the	DT	O	B-NP	O
24	18	fruit	NN	O	I-NP	B-Animal
24	19	fly	VBP	O	B-VP	I-Animal
24	20	genome	NN	O	B-NP	B-Jour
24	21	suggests	VBZ	O	B-VP	O
24	22	may	MD	O	B-VP	O
24	23	be	VB	O	I-VP	O
24	24	the	DT	O	B-NP	O
24	25	case	NN	O	I-NP	O
24	26	COMMA	COMMA	O	O	O
24	27	Venter	NNP	O	B-NP	B-Peop
24	28	said	VBD	O	B-VP	O
24	29	he	PRP	O	B-NP	O
24	30	would	MD	O	B-VP	O
24	31	raise	VB	O	I-VP	O
24	32	his	PP$	O	B-NP	O
24	33	estimate	NN	O	I-NP	O
24	34	of	IN	O	B-PP	O
24	35	the	DT	O	B-NP	O
24	36	number	NN	O	I-NP	O
24	37	of	IN	O	B-PP	O
24	38	human	JJ	O	B-NP	B-Animal
24	39	gene	NN	O	I-NP	O
24	40	by	IN	O	B-PP	O
24	41	25	CD	O	B-NP	B-NumPercent
24	42	percent	NN	O	I-NP	I-NumPercent
24	43	.	.	O	O	O

25	0	A	DT	O	B-NP	O
25	1	publicly	RB	O	I-NP	O
25	2	financed	VBN	O	I-NP	O
25	3	consortium	NN	O	I-NP	O
25	4	of	IN	O	B-PP	O
25	5	university	NN	O	B-NP	B-OrgUniv
25	6	centers	NNS	O	I-NP	O
25	7	has	VBZ	O	B-VP	O
25	8	said	VBN	O	I-VP	O
25	9	it	PRP	O	B-NP	O
25	10	will	MD	O	B-VP	O
25	11	issue	VB	O	I-VP	O
25	12	a	DT	O	B-NP	O
25	13	90	CD	O	I-NP	B-NumPercent
25	14	percent	NN	O	I-NP	I-NumPercent
25	15	complete	JJ	O	I-NP	O
25	16	draft	NN	O	I-NP	O
25	17	of	IN	O	B-PP	O
25	18	the	DT	O	B-NP	O
25	19	human	JJ	O	I-NP	B-Animal
25	20	genome	NN	O	I-NP	B-Jour
25	21	by	IN	O	B-PP	O
25	22	next	JJ	O	B-NP	O
25	23	spring	NN	O	I-NP	O
25	24	.	.	O	O	O
